- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Oncolytic herpes simplex virus and immunotherapy ; volume:19 ; number:1 ; day:18 ; month:12 ; year:2018 ; pages:1-11 ; date:12.2018
BMC immunology ; 19, Heft 1 (18.12.2018), 1-11, 12.2018
- Creator
-
Ma, Wenqing
He, Hongbin
Wang, Hongmei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12865-018-0281-9
- URN
-
urn:nbn:de:101:1-2019020622171011303779
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ma, Wenqing
- He, Hongbin
- Wang, Hongmei
- SpringerLink (Online service)
Other Objects (12)
Advances in antitumour therapy with oncolytic herpes simplex virus combinations
Immunotherapy Development to Target Herpes Simplex Virus Infections
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1
Herpes simplex virus
Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta
Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
Über das Herpes simplex-Virus
Die genitale Herpes simplex Virus Typ-2 Infektion [Herpes-simplex-Virus-Typ-Infektion] nach oraler Immunisierung mit lebendem Herpes-simplex-Virus Typ-1 [Typ]
Genetische Studien mit Herpes Simplex Virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with the Vaccinia virus GLV-1h68 and the Herpes simplex virus T-VEC
Serologische Untersuchungen bei Herpes simplex recidivans unter Berücksichtigung der Herpes simplex-Virus Typen
Advances in antitumour therapy with oncolytic herpes simplex virus combinations
Immunotherapy Development to Target Herpes Simplex Virus Infections
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1
Herpes simplex virus
Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta
Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
Über das Herpes simplex-Virus
Die genitale Herpes simplex Virus Typ-2 Infektion [Herpes-simplex-Virus-Typ-Infektion] nach oraler Immunisierung mit lebendem Herpes-simplex-Virus Typ-1 [Typ]
Genetische Studien mit Herpes Simplex Virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with the Vaccinia virus GLV-1h68 and the Herpes simplex virus T-VEC
Serologische Untersuchungen bei Herpes simplex recidivans unter Berücksichtigung der Herpes simplex-Virus Typen
Advances in antitumour therapy with oncolytic herpes simplex virus combinations
Immunotherapy Development to Target Herpes Simplex Virus Infections
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1
Herpes simplex virus
Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta
Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
Über das Herpes simplex-Virus
Die genitale Herpes simplex Virus Typ-2 Infektion [Herpes-simplex-Virus-Typ-Infektion] nach oraler Immunisierung mit lebendem Herpes-simplex-Virus Typ-1 [Typ]
Genetische Studien mit Herpes Simplex Virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with the Vaccinia virus GLV-1h68 and the Herpes simplex virus T-VEC